1. Home
  2. KNSA vs BANC Comparison

KNSA vs BANC Comparison

Compare KNSA & BANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • BANC
  • Stock Information
  • Founded
  • KNSA 2015
  • BANC 1941
  • Country
  • KNSA United Kingdom
  • BANC United States
  • Employees
  • KNSA N/A
  • BANC N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • BANC Major Banks
  • Sector
  • KNSA Health Care
  • BANC Finance
  • Exchange
  • KNSA Nasdaq
  • BANC Nasdaq
  • Market Cap
  • KNSA 2.1B
  • BANC 2.2B
  • IPO Year
  • KNSA 2018
  • BANC N/A
  • Fundamental
  • Price
  • KNSA $27.12
  • BANC $15.28
  • Analyst Decision
  • KNSA Strong Buy
  • BANC Buy
  • Analyst Count
  • KNSA 6
  • BANC 11
  • Target Price
  • KNSA $39.33
  • BANC $17.18
  • AVG Volume (30 Days)
  • KNSA 980.0K
  • BANC 2.5M
  • Earning Date
  • KNSA 07-29-2025
  • BANC 07-23-2025
  • Dividend Yield
  • KNSA N/A
  • BANC 2.65%
  • EPS Growth
  • KNSA N/A
  • BANC N/A
  • EPS
  • KNSA N/A
  • BANC 0.65
  • Revenue
  • KNSA $481,166,000.00
  • BANC $964,190,000.00
  • Revenue This Year
  • KNSA $37.21
  • BANC $8.08
  • Revenue Next Year
  • KNSA $5.32
  • BANC $10.50
  • P/E Ratio
  • KNSA N/A
  • BANC $23.47
  • Revenue Growth
  • KNSA 59.45
  • BANC 415.34
  • 52 Week Low
  • KNSA $17.82
  • BANC $11.52
  • 52 Week High
  • KNSA $30.69
  • BANC $18.08
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 43.14
  • BANC 65.32
  • Support Level
  • KNSA $28.19
  • BANC $14.88
  • Resistance Level
  • KNSA $29.58
  • BANC $15.23
  • Average True Range (ATR)
  • KNSA 0.93
  • BANC 0.37
  • MACD
  • KNSA -0.13
  • BANC 0.03
  • Stochastic Oscillator
  • KNSA 3.15
  • BANC 95.24

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

Share on Social Networks: